BioMarin Pharmaceutical Inc. (BMV:BMRN)

BioMarin Pharmaceutical Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 25, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	204,263	205,549	261,031	307,053	375,171	332,528
Market Cap Growth	-20.66%	-21.25%	-14.99%	-18.16%	12.82%	4.98%
Enterprise Value	188,473	189,821	254,201	306,536	371,611	332,698
Last Close Price	1043.03	980.00	1700.00	1375.00	2132.23	1845.00
PE Ratio	32.52	32.72	29.35	108.34	135.87	-
PS Ratio	3.52	3.54	4.39	7.51	9.18	8.79
PB Ratio	1.86	1.88	2.21	3.67	4.18	3.80
P/TBV Ratio	2.03	2.05	2.44	4.10	4.73	4.41
P/FCF Ratio	15.65	15.75	25.70	290.28	350.06	77.63
P/OCF Ratio	13.70	13.79	21.87	114.04	109.34	53.26
EV/Sales Ratio	3.40	3.27	4.28	7.50	9.09	8.79
EV/EBITDA Ratio	14.92	14.59	21.38	62.49	121.62	481.22
EV/EBIT Ratio	16.83	16.20	25.73	97.60	348.42	-
EV/FCF Ratio	14.44	14.54	25.03	289.80	346.74	77.67
Debt / Equity Ratio	0.11	0.11	0.11	0.23	0.24	0.26
Debt / EBITDA Ratio	0.88	0.88	1.08	3.73	6.58	23.56
Debt / FCF Ratio	0.89	0.89	1.30	18.12	20.38	5.38
Net Debt / Equity Ratio	-0.15	-0.15	-0.09	0.01	-0.04	0.03
Net Debt / EBITDA Ratio	-1.27	-1.27	-0.88	0.21	-1.10	3.25
Net Debt / FCF Ratio	-1.27	-1.27	-1.03	0.96	-3.12	0.52
Asset Turnover	0.44	0.44	0.41	0.37	0.34	0.31
Inventory Turnover	0.47	0.47	0.50	0.53	1.38	1.49
Quick Ratio	3.25	3.25	2.96	1.45	2.98	2.54
Current Ratio	5.21	5.21	5.33	2.51	4.67	4.16
Return on Equity (ROE)	5.94%	5.94%	8.05%	3.51%	3.19%	-1.53%
Return on Assets (ROA)	5.58%	5.58%	4.29%	1.76%	0.55%	-0.78%
Return on Invested Capital (ROIC)	9.09%	9.12%	7.35%	3.50%	1.18%	-1.74%
Return on Capital Employed (ROCE)	9.50%	9.50%	7.40%	3.30%	0.90%	-1.40%
Earnings Yield	3.08%	3.06%	3.41%	0.92%	0.74%	-0.40%
FCF Yield	6.39%	6.35%	3.89%	0.34%	0.29%	1.29%
Buyback Yield / Dilution	-0.35%	-0.35%	-2.67%	-1.39%	-3.34%	4.61%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.